ADRENAL
2018 Sepsis
? ICUs
? patients
Hydrocortisone 200 mg/day as a continuous infusion for 7 days or discharge from ICU
Clinical Question
In critically ill patients with septic shock, does hydrocortisone compared
with placebo, reduce 90 day mortality?
Critical Appraisal
Key findings
No difference in mortality but significantly reduced ICU LOS, MV days, delay to resolution of shock and blood transfusions
Critique
Underreporting of clinically relevant adverse effects
- Population
- Sepsis
- Population Details
- Not recorded
- Intervention Arms
-
Hydrocortisone 200 mg/day as a continuous infusion for 7 days
Hydrocortisone 200 mg/day as a continuous infusion for 7 days - Control Arms
-
Placebo
- Primary Outcome
- 90 day mortality
- Secondary Outcomes
- No difference in mortality , Hastened the reversal of shock , Decreased ICU LOS , Less mechanically ventilated days , Less blood transfusions
- P Value
- Not recorded
Outcome Results
Not recorded
Primary location: Worldwide
ANZICS
Landmark trial